Hims&Hers Health Q4 earnings fall short of estimates
Investing.com -- Hims&Hers Health Inc (NYSE: HIMS) reported weaker-than-expected fourth-quarter earnings that overshadowed the telehealth company's revenue that topped Wall Street estimates.
Hims Hers Health fell 13% in recent afterhours trading.
For the three months ended Dec. 31, the company reported earnings of $0.11 on revenue of $481.1 million, compared with analyst estimates for earnings of $0.17 on revenue of $469.3M.
"Revenue excluding our GLP-1 offering increased 43% year-over-year to over $1.2 billion in 2024, meeting our previous 2025 revenue target a year early," the company said.
For Q1, the company expects revenue in a range of $520M to $540M, compared with analyst expectations of $494.6M, and adjusted earnings before interest, taxes, depreciation, and amortization of $55M to $65M.
Looking further ahead, the company full-year 2025 revenue in range of $2.3B to $2.4B and adjusted EBITDA of $270M to $320M.